camostat has been researched along with Cancer of Lung in 1 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, H | 1 |
| Lu, L | 1 |
| Peng, Z | 1 |
| Chen, LL | 1 |
| Meng, X | 1 |
| Zhang, C | 1 |
| Ip, JD | 1 |
| Chan, WM | 1 |
| Chu, AW | 1 |
| Chan, KH | 1 |
| Jin, DY | 1 |
| Chen, H | 1 |
| Yuen, KY | 1 |
| To, KK | 1 |
1 other study available for camostat and Cancer of Lung
| Article | Year |
|---|---|
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chlorocebus aethiops; Chloroquine; COVID- | 2022 |